We are live on ! Find out more
CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Est. Return 17.37%
This Fund
S&P 500
This Quarter Est. Return
-10.73%
1 Year Est. Return
+17.37%
3 Year Est. Return
+18.06%
5 Year Est. Return
+62.97%
10 Year Est. Return
AUM
$837M
AUM Growth
+$481M
Cap. Flow
+$558M
Cap. Flow %
66.64%
Top 10 Hldgs %
21.72%
Holding
2,317
New
637
Increased
1,055
Reduced
335
Closed
76
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXT icon
1551
Textron
TXT
$14.9B
$7K ﹤0.01%
+153
New +$8.6K
UNIT
1552
Uniti Group
UNIT
$2.34B
$7K ﹤0.01%
470
+315
+203% +$5.92K
URA icon
1553
Global X Uranium ETF
URA
$5.66B
$7K ﹤0.01%
600
USAC icon
1554
USA Compression Partners
USAC
$3.73B
$7K ﹤0.01%
+600
New +$8.92K
UTHR icon
1555
United Therapeutics
UTHR
$25.7B
$7K ﹤0.01%
72
+31
+76% +$3.59K
VNO icon
1556
Vornado Realty Trust
VNO
$7.51B
$7K ﹤0.01%
114
-131
-53% -$8.97K
WAB icon
1557
Wabtec
WAB
$50.1B
$7K ﹤0.01%
113
-34
-23% -$2.97K
WK icon
1558
Workiva
WK
$3.43B
$7K ﹤0.01%
200
RJI
1559
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$7K ﹤0.01%
+1,600
New +$8.55K
RP
1560
DELISTED
RealPage, Inc.
RP
$7K ﹤0.01%
146
+17
+13% +$888
BITA
1561
DELISTED
Bitauto Holdings Limited
BITA
$7K ﹤0.01%
+300
New +$5.83K
LOR
1562
DELISTED
Lazard World Dividend & Income Fund, Inc.
LOR
$7K ﹤0.01%
897
HZNP
1563
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7K ﹤0.01%
382
+19
+5% +$372
GFN
1564
DELISTED
General Finance Corporation
GFN
$7K ﹤0.01%
+751
New +$9.78K
ENV
1565
DELISTED
ENVESTNET, INC.
ENV
$7K ﹤0.01%
151
+98
+185% +$5.25K
AL
1566
DELISTED
Air Lease Corp
AL
$6K ﹤0.01%
226
-75
-25% -$2.86K
AMP icon
1567
Ameriprise Financial
AMP
$48.8B
$6K ﹤0.01%
61
APTV icon
1568
Aptiv
APTV
$12.1B
$6K ﹤0.01%
113
-29
-20% -$2.1K
CDNS icon
1569
Cadence Design Systems
CDNS
$92.6B
$6K ﹤0.01%
158
CMG icon
1570
Chipotle Mexican Grill
CMG
$47.5B
$6K ﹤0.01%
+750
New +$6.78K
CORT icon
1571
Corcept Therapeutics
CORT
$12.2B
$6K ﹤0.01%
506
-769
-60% -$10.2K
CRL icon
1572
Charles River Laboratories
CRL
$11.1B
$6K ﹤0.01%
58
-7
-11% -$876
DDD icon
1573
3D Systems Corp
DDD
$462M
$6K ﹤0.01%
593
+200
+51% +$2.74K
DFJ icon
1574
WisdomTree Japan SmallCap Dividend Fund
DFJ
$383M
$6K ﹤0.01%
+108
New +$7.58K
DKS icon
1575
Dick's Sporting Goods
DKS
$18B
$6K ﹤0.01%
200
-200
-50% -$6.95K

Similar funds

Concourse Financial Group Securities's Q4 2018 Portfolio in Review

As of Q4 2018, Concourse Financial Group Securities held 2,317 positions worth $837M, up 135% from $356M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Concourse Financial Group Securities deployed $558M of net new capital in Q4 2018, opening 637 new positions and adding to 1,055 existing holdings. Its largest new stake was iShares Global Consumer Staples ETF: 234,390 shares worth $10.8M.

By sector, the portfolio is most concentrated in Financials at 4% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was VanEck Fallen Angel High Yield Bond ETF, an estimated $3.87M trimmed.

  • Concourse Financial Group Securities's largest Q4 2018 buy was iShares Global Consumer Staples ETF: 234,390 shares worth $10.8M.
  • Concourse Financial Group Securities added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $23.6M increase.
  • Concourse Financial Group Securities's biggest Q4 2018 reduction was VanEck Fallen Angel High Yield Bond ETF, cutting an estimated $3.87M.
  • Concourse Financial Group Securities fully exited Fidelity MSCI Real Estate Index ETF in Q4 2018, selling an estimated $243K.
  • Concourse Financial Group Securities's ten largest holdings make up 22% of its $837M portfolio in Q4 2018.
  • Concourse Financial Group Securities opened 637 new positions and closed 76 in Q4 2018.
  • Concourse Financial Group Securities's portfolio value rose 135% quarter-over-quarter to $837M.

Based on Concourse Financial Group Securities's 13F filing for Q4 2018, filed 14 Feb 2019.